Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001209191-22-061246

Director bought 934,581 shares at $10.70 ($10,000,017)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rhodes Jason P Director 2022-12-12 Purchase +934,581 $10.70 $10,000,017 934,581 I
Open-market purchases · 934,581 sh · avg $10.70 · $10,000,017
Loading xslF345X03/doc4.xml…